FierceBiotech 13 feb 2026 With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
FierceBiotech 12 feb 2026 UPDATE: After Moderna's rebuke, HHS stands behind FDA decision to spurn mRNA flu filing
FierceBiotech 11 feb 2026 Moderna hit with FDA refusal-to-file letter for mRNA flu shot, issues sharp rebuke of agency's rationale
FierceBiotech 30 ene 2026 Moderna offloads late-stage rare disease drug to Recordati for $50M upfront
FierceBiotech 23 ene 2026 Anti-vaccine sentiment pushes Moderna away from new late-stage infectious disease trials
FierceBiotech 20 ene 2026 Merck-Moderna cancer vaccine sustains 49% melanoma risk reduction at 5 years
FierceBiotech 18 dic 2025 After HHS funding was scrapped, CEPI fronts up to $54M to carry Moderna's pandemic influenza vaccine into phase 3
FierceBiotech 25 nov 2025 <a href="https://www.fiercebiotech.com/biotech/modernas-reshaping-rolls-3-more-pipeline-purges" hreflang="en">Moderna's reshaping rolls on with 3 more pipeline purges</a> #Moderna reshaping #vaccine Spikevax